Under-Eye Filler Migration and "Puffy Bags" When Dissolving Isn't Enough and Surgery Is the Answer

A patient arrives at a consultation, sometimes years after her original tear trough filler treatment, with a specific and consistent set of complaints: persistent puffiness under the eyes that looks worse in the morning and under certain lighting, a bluish or grayish discoloration through the thin under-eye skin, and a sense that the area looks "heavier" or more tired than it did before she ever got filler in the first place, despite having sought treatment originally to look more rested. She has often already tried one or more rounds of hyaluronidase, the enzyme used to dissolve hyaluronic acid filler, sometimes with partial improvement and sometimes with none at all. She wants to know what's actually happening and whether it can be fixed.

This is one of the most common and most frustrating presentations in aesthetic medicine right now, frustrating both because it's avoidable with the right initial treatment approach and because, once it develops, it isn't always straightforward to reverse. Working through it requires ruling out several distinct possibilities that can all present with a similar-looking puffy, discolored under-eye area.

Ruling In: Filler Migration

One possibility is that the filler itself has physically moved from its original injection site over time, a phenomenon often called migration. This can happen when filler is placed too superficially, in a thin-skinned area with limited overlying soft tissue like the tear trough, or when the product used has a tendency to attract and hold water once integrated into the tissue, or simply as a mechanical consequence of the area's constant movement from blinking and facial expression over months and years.

When migration is the primary issue, the puffiness typically has a somewhat irregular, sometimes asymmetric quality, and it may extend slightly beyond where the original injection was placed, most classically toward the lower eyelid or upper cheek. A careful physical exam, sometimes aided by gently pressing on the area to assess mobility and consistency of the fullness, can help distinguish filler-related fullness from other causes, though this isn't always straightforward without treatment history and, in some cases, imaging.

Ruling In: The Tyndall Effect

A second, related but mechanistically distinct possibility is the Tyndall effect, a bluish or grayish discoloration that occurs when hyaluronic acid filler is placed too superficially under thin under-eye skin. This isn't about the filler physically moving, it's an optical phenomenon: light scattering differently through skin with filler sitting close to the surface, producing a visible blue-gray tint that can look like a bruise or dark circle that never resolves, distinct from puffiness itself but often occurring alongside it and frequently confused with simple under-eye discoloration unrelated to filler.

Distinguishing Tyndall effect from other causes of under-eye discoloration matters because it directly implicates the depth of the original filler placement as the root cause, which has direct implications for how successfully it can be treated, both with dissolving and with any subsequent treatment approach.

Ruling In: Fluid Retention Independent of the Filler Itself

A third possibility, and one that's sometimes overlooked, is that hyaluronic acid filler is inherently hygroscopic, meaning it attracts and binds water. In an area as thin-skinned and prone to fluid shifts as the under-eye, this property can cause the treated area to look puffier than the surrounding tissue, particularly after salty food, alcohol, poor sleep, or simply first thing in the morning, even when the filler hasn't migrated and Tyndall effect isn't present. This water-attracting property is actually why hyaluronic acid filler is used in the first place, but in an area with such thin, delicate overlying skin and such visible fluid dynamics, it becomes a double-edged property that other facial areas, with thicker skin, tolerate much better.

Ruling In: Product-Specific Factors

Not all hyaluronic acid fillers behave identically once placed in the delicate under-eye tissue, and product selection is itself a relevant factor in this diagnostic picture. Fillers with a higher water-binding capacity, generally products engineered with a higher degree of cross-linking or specific rheological properties intended for volumizing rather than fine-line correction, are more prone to visible puffiness and prolonged swelling when placed in the thin under-eye area compared to lighter, less hygroscopic formulations specifically designed for this delicate region. A filler that performs beautifully in the cheek or nasolabial fold, where the overlying tissue is thicker and better able to camouflage subtle swelling and irregularity, can behave very differently and far less predictably when placed in the tear trough, where the skin is among the thinnest on the entire face.

This is part of why tear trough filler is widely considered one of the more technically demanding injection sites in facial aesthetics, despite sometimes being marketed and priced similarly to more straightforward, lower-risk injection areas. A practitioner's product selection, not just their injection technique and depth, is a meaningful variable in whether a patient ends up with the presentation described throughout this article.

Ruling In: Time and Cumulative Treatment History

For patients who have had tear trough filler repeated over multiple sessions across months or years, sometimes with different practitioners or different products layered on top of each other without a clear record of what was originally placed, the cumulative treatment history itself becomes a relevant diagnostic factor. Repeated touch-up sessions, particularly when performed without allowing adequate time to assess how prior filler has settled and behaved, can result in a gradual accumulation of product that individually seemed reasonable at each visit but collectively creates significant volume and increased risk of the complications discussed throughout this piece.

This is one of the more difficult aspects of working up these cases clinically, since patients frequently cannot recall precisely how much filler was placed, when, or with what specific product, particularly if multiple practitioners were involved over an extended period. This is exactly why obtaining whatever treatment records are available, and being as specific as possible about treatment history during a workup, meaningfully improves a surgeon's ability to accurately diagnose what's actually happening in a given case.

Why an Experienced Injector Matters as Much as the Product Itself

Given how frequently product-related and anatomical factors intersect in this presentation, it's worth being direct about the role of injector experience and technique specifically in the tear trough region. This is an area where subtle differences in depth of placement, often a matter of just a millimeter or two, can be the difference between a smooth, natural-looking correction and the puffy, discolored presentation this article describes. An experienced injector working specifically in this region understands the precise anatomical layer required, typically deep, just above the periosteum in appropriate candidates, to minimize the risk of superficial placement that leads to Tyndall effect and migration.

This is also an area where conservative, incremental treatment tends to produce more predictable, longer-lasting satisfactory results than an aggressive, high-volume approach in a single session, since the tissue's response to filler in this specific location is less forgiving of overcorrection than thicker-skinned facial areas.

Ruling Out: The Patient's Own Anatomy

Before attributing a puffy under-eye appearance entirely to filler, it's important to evaluate what the patient's baseline anatomy actually was before any treatment. Some degree of under-eye fullness is caused by fat pad prolapse, sometimes called eye bags in casual conversation, a normal age-related or genetic change where the fat that normally cushions the eye begins to bulge forward against weakened supporting tissue, independent of any filler treatment at all. In some cases, a patient with mild pre-existing fat pad prolapse was treated with filler specifically to camouflage or blend the transition between the lower eyelid and the cheek, and what she's now noticing is a combination of the original anatomical issue becoming more apparent as she's aged further, layered on top of filler-related puffiness.

This distinction matters enormously for treatment planning, because it changes the answer from "we need to remove or dissolve something" to "we may need to address underlying anatomy surgically in addition to, or instead of, dissolving filler."

The Diagnosis: Why Dissolving Doesn't Always Fully Resolve the Problem

Hyaluronidase can break down hyaluronic acid filler, and it remains the first and most appropriate step for a patient presenting with these symptoms, particularly when filler migration or excess volume is a clear contributor. But dissolving doesn't address every mechanism at play in this presentation. If Tyndall effect discoloration has been present for a long period, some patients experience residual discoloration even after the filler causing it has been dissolved, since the skin and surrounding tissue can undergo some degree of change from prolonged compression and altered light-scattering that doesn't necessarily reverse instantly. If the underlying issue includes true fat pad prolapse that either predated the filler or has progressed independently, dissolving the filler will not address that anatomical component at all, since there was never any filler contributing to it in the first place.

This is the diagnostic pivot point that determines whether a patient's case resolves with dissolving alone or requires a different approach: is the puffiness purely filler-related, or is there an underlying anatomical component that filler was masking rather than causing.

The Resolution: When Surgery Becomes the Right Answer

For patients whose puffy, tired-looking under-eye appearance is driven substantially by true fat pad prolapse, whether that existed before filler treatment or has developed or progressed since, a lower blepharoplasty is often the more definitive and appropriate solution. This procedure addresses the underlying anatomical cause directly, repositioning or conservatively removing prolapsed fat and, when appropriate, addressing skin laxity, rather than relying on filler to camouflage a structural issue that filler was never actually designed to correct.

For patients who have persistent under-eye puffiness or fullness after filler has been dissolved, Dr. William Harris evaluates whether the remaining concern is related to filler, underlying fat pad prolapse, skin laxity, or a combination of factors. When surgery is appropriate, a lower blepharoplasty can address the underlying anatomy directly rather than continuing to rely on filler to camouflage it.

For patients with a combination of factors, some genuine fat pad prolapse alongside filler-related puffiness or discoloration, treatment often needs to be sequenced. Dissolving any remaining problematic filler, waiting an appropriate interval for full resolution of dissolving-related swelling and for the skin to settle, and then reassessing what anatomical issues remain before determining whether blepharoplasty is warranted, is a more careful and ultimately more successful approach than assuming a single treatment will resolve a multi-factor presentation.

Why This Combination Is Becoming More Common

Part of why this presentation has become such a frequent topic in patient forums and consultations is a broader pattern in aesthetic medicine: tear trough filler is often used, sometimes appropriately and sometimes not, to delay or avoid a surgical conversation about blepharoplasty, particularly in younger patients hesitant about surgery. In patients with genuinely mild hollowing and no significant fat pad prolapse, this can work well and delay or entirely avoid the need for surgery. In patients with more significant underlying prolapse, filler placed to camouflage the transition can mask the anatomical problem temporarily while, in some cases, adding its own layer of complication through migration, Tyndall effect, or fluid retention on top of the original issue, ultimately making the presentation more complex rather than resolving it.

This is precisely why an honest evaluation at the time of the original filler consultation, one that correctly identifies whether a patient's under-eye concern is primarily volume loss that filler can appropriately address, versus fat pad prolapse that filler is likely to mask rather than fix, matters so much in preventing this outcome in the first place.

What Recovery From Corrective Treatment Actually Involves

Patients who reach the resolution stage of this case, whether that means additional dissolving, a period of observation, or ultimately blepharoplasty, benefit from understanding what recovery from each path actually looks like, since expectations here directly affect satisfaction with the outcome. Recovery from hyaluronidase treatment itself is typically brief, with any associated swelling from the dissolving process resolving within days to at most a couple of weeks, though the underlying puffiness or discoloration that prompted treatment may take longer to fully resolve or may only partially improve, as discussed earlier in this piece.

Recovery from lower blepharoplasty, when it becomes the appropriate solution, is more involved, typically including a week to ten days of visible bruising and swelling, with residual, more subtle swelling continuing to resolve over the following several weeks to a couple of months. Patients moving from a filler-only approach to blepharoplasty sometimes underestimate this difference in recovery timeline, having grown accustomed to the essentially downtime-free nature of filler treatment, which makes clear, direct communication about this contrast an important part of a thorough surgical consultation for patients coming from this specific treatment history.

What a Thorough Evaluation Actually Looks Like

For a patient presenting with this complaint, a proper evaluation includes a detailed history of what was injected, when, by whom, and how much, if that information is available, a physical exam assessing the mobility, consistency, and exact location of the fullness, and often a trial of hyaluronidase as both a diagnostic and therapeutic step, since the response to dissolving can itself help clarify how much of the presentation is filler-related versus anatomical. Photography under consistent lighting, ideally compared to any available pre-filler photos, can also help distinguish what has changed since the original treatment from what may represent baseline anatomy that was always present.